Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.002 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.45 | 0.002 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.004 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.004 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.43 | 0.004 |